Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma
Completed · Phase 2
Conditions studied: Lymphoma
In brief
RATIONALE: Drugs used in chemotherapy, such as methotrexate, procarbazine, lomustine, dexamethasone, and cytarabine, use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have primary CNS lymphoma.
Key facts
- Study ID
- NCT00074191
- Run by
- OHSU Knight Cancer Institute
- People needed
- 1
- Starts
- 2000-01-01
- Expected to finish
- 2000-10-01
- Last updated by the study team
- 2017-04-21
Who can join
Age: 16 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Oregon Health & Science University Cancer Institute — Portland, Oregon, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.